News

RESI_Logo.PNG

December 7, 2021

Calendar_Logo.001.png

Summit Biomedical Imaging To Attend Digital RESI Meeting 

January 11 To January 13 , 2022

New York, NY -- Summit Biomedical Imaging ("Summit"), a cancer diagnostic company announced today that the company will attend the virtual Redefining Early Stage Investments ("RESI") Meeting from January 11 to January 13. (Link)

NCI_Logo.png

Summit Biomedical Imaging Awarded $1.5M NCI Phase II STTR Grant

New York, NY -- Summit Biomedical Imaging ("Summit"), a cancer diagnostic company announced today that the National Institute of Cancer ("NCI") of the National Institute of Health ("NIH") has awarded Summit approximately $1.5M over two years in a Phase II grant as part of the Small Business Technology Transfer ("STTR") program. 

August 19, 2021

Calendar_Logo.001.png
NCI_Logo.png

July 12, 2021

Calendar_Logo.001.png

Summit Biomedical Imaging Selected By NCI For NCI SBIR Investor Initiatives

New York, NY -- Summit Biomedical Imaging ("Summit"), a cancer diagnostic company announced today that the National Institute of Cancer ("NCI") of the National Institute of Health ("NIH") has selected Summit

as one of the showcase companies for the 2021-2022 NCI SBIR Investor initiatives. (Link)

EJNMMI_Logo.PNG

May 5, 2021

Calendar_Logo.001.png

Positive Data Published From A Phase I Study Of A PARP1-Targeted Topical Fluorophore For The Detection Of Oral Cancer

New York, NY -- Positive results from a phase I study of a PARP1-targeted topical fluorophore for the detection of oral cancer were published in the peer-reviewed journal of European Journal of Nuclear Medicine and Molecular Imaging. (Link)

Summit Biomedical Imaging Selected By NCI For TABA Needs Assessment

New York, NY -- Summit Biomedical Imaging ("Summit"), a cancer diagnostic company announced today that the National Institute of Cancer ("NCI") of the National Institute of Health ("NIH") has selected Summit to participate in the Technical and Business Assistance ("TABA") Needs Assessment program.

December 22, 2020

Calendar_Logo.001.png
NCI_Logo.png
NCI_Logo.png

Summit Biomedical Imaging Awarded $260k NCI Phase I STTR Grant

New York, NY -- Summit Biomedical Imaging ("Summit"), a cancer diagnostic company announced today that the National Institute of Cancer ("NCI") of the National Institute of Health ("NIH") has awarded Summit approximately $260k over one year in a Phase I grant as part of the Small Business Technology Transfer ("STTR") program. 

September 10, 2020

Calendar_Logo.001.png